Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash Flows Provided By (Used In) Operating Activities:
Net Loss	$ (2,603,500)	$ (2,850,200)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	296,900	187,700
Stock-based compensation expense	417,000	580,500
Company payment of employee taxes for stock-based compensation	(1,800)
Change in fair value of derivative instruments – warrants	(1,665,900)	(680,100)
Accretion of warrants liability for consulting services	(67,000)	35,700
Accretion of equity warrants for consulting services	(3,600)	11,800
Revenue deferred to future periods	(2,756,500)	2,725,500
Recognition of deferred revenue	2,320,600	(3,102,600)
Changes in severance liability	(55,000)	(122,300)
Changes in deferred rent	(9,300)	(19,900)
Changes to allowance for doubtful accounts	(23,800)	(4,300)
Changes in operating assets and liabilities:
Accounts receivable	377,600	169,800
Prepaid expenses	(53,100)	87,800
Accounts payable and accrued expenses	(231,800)	226,600
Other assets	(100)	15,200
Net Cash Used in Operating Activities	(4,059,300)	(2,738,800)
Cash Flows Used In Investing Activities:
Capital expenditures	(45,300)	(75,800)
Capitalized software development costs		(506,900)
Net Cash Used In Investing Activities	(45,300)	(582,700)
Cash Flows Provided By (Used In) Financing Activities:
Proceeds from exercise of warrants	260,000	2,615,300
Proceeds from exercise of employee stock options	47,800	302,700
Cost associated with private placement of common stock and warrants	(20,000)
Proceeds from private placement of common stock and warrants	3,390,000
Net Cash Provided By Financing Activities	3,677,800	2,918,000
Net Decrease in Cash	(426,800)	(403,500)
Cash - Beginning of Period	2,430,700	3,960,600
Cash - End of Period	$ 2,003,900	$ 3,557,100